Ford calls back 870,000 F-150 trucks over the risks of unexpected electric parking brake activation, which caused by a potential wiring issue.
$20 an hour, clothing stipend, meals: How a Big Four firm is trying to get teens interested in accounting
KPMG is offering summer interns $20-$22 an hour to encourage more teenagers to consider a career in accounting and help fix the talent pipeline problem.
Analysts see hope in Intel’s earnings but remain wary of structural issues
Analysts praised Intel’s second-quarter earnings but expressed concerns about continued execution and pressure from shifting enterprise spend priorities.
The Investing Club’s top 10 things to watch in the stock market Friday
We’re watching the bond market Friday after Thursday’s spike in yields triggered a late-day reversal for equities.
Google’s building A.I. into robots to teach them to throw out the trash
The Robotics Transformer 2 (RT-2) is a vision-language-action model trained on information on the web that can be translated into actions for the robot.
You have a month left to get your share of Facebook’s $725 million settlement — here’s how
Meta users have less than one month left to apply for their share of a $725 million settlement over Facebook privacy violations.
Key Fed inflation rate falls to lowest annual level in nearly 2 years
Inflation showed further signs of cooling in June, according to a gauge released Friday that the Federal Reserve follows closely.
As interest rates, inventory issues keep car costs high, what drivers are doing to make ownership possible
The average monthly auto payment reached $733, a new record, in the second quarter of the year. Some drivers are extending repayment or putting off purchases.
Here are Friday’s biggest analyst calls: Apple, Southwest, Roku, Skechers, First Solar, Crocs & more
Here are the biggest calls on Wall Street on Friday.
Biogen to buy Reata for $6.5 billion to bulk up rare disease portfolio
Biogen agreed to buy biotech firm Reata Pharmaceuticals for nearly $6.5 billion to bolster its position in the rare disease drugs market.
- « Previous Page
- 1
- …
- 560
- 561
- 562
- 563
- 564
- …
- 1899
- Next Page »